Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8+T Cell Immunity-Reference-Cited by-同舟云学术

Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8+T Cell Immunity

Published:2022-09 Issue: Volume:Volume 17 Page:4449-4468
ISSN:1178-2013
Container-title:International Journal of Nanomedicine
language:en
Short-container-title:IJN

Author:

Domvri Kalliopi,Petanidis Savvas,Zarogoulidis Paul,Anestakis Doxakis^ORCID,Charalampidis Charalampos,Tsavlis Drosos,Huang Haidong,Freitag Lutz,Hohenforst-Schmidt Wolfgang,Matthaios Dimitris,Katopodi Theodora,Porpodis Konstantinos

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science

Reference41 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Lung cancer: current therapies and new targeted treatments

3. Elements of cancer immunity and the cancer–immune set point

4. The Intersection between Tumor Angiogenesis and Immune Suppression

5. Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects;Cells;2024-09-11

2. Nanomaterial‐Based Strategies for Preventing Tumor Metastasis by Interrupting the Metastatic Biological Processes;Advanced Healthcare Materials;2024-03-08

3. Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies;Current Cancer Drug Targets;2024-03

4. Profiling regulatory T lymphocytes within the tumor microenvironment of breast cancer via radiomics;Cancer Medicine;2023-12

5. Regulatory T cells in lung disease and transplantation;Bioscience Reports;2023-10